<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">3905</id>
  <title>T3D3850</title>
  <common-name>Flusilazole</common-name>
  <description>Flusilazole (DPX-H6573) is an organosilicon fungicide invented by DuPont, which is used to control fungal infections on a variety of fruit and vegetable crops. It is moderately toxic to animals and has been shown to produce birth defects and embryotoxicity at high doses.</description>
  <cas>85509-19-9</cas>
  <pubchem-id>73675</pubchem-id>
  <chemical-formula>C16H15F2N3Si</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point>48°C</melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility></solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure></route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>Flusilazole has a dose-related inhibition of serum testosterone and estradiol concentrations in rats. This inhibition of testosterone and estradiol biosynthesis may disrupt the hypothalamus–pituitary–testis axis, resulting in overstimulation of the testicular endocrine tissues and increase the risk of Leydig-cell tumours.</mechanism-of-toxicity>
  <metabolism></metabolism>
  <toxicity>LD50 (rat, oral) =1110 mg/kg (m)
LD50 (rat, dermal) &gt;2000 mg/kg</toxicity>
  <lethaldose></lethaldose>
  <carcinogenicity>Not listed by IARC.</carcinogenicity>
  <use-source>This is a man-made compound that is used as a pesticide.</use-source>
  <min-risk-level></min-risk-level>
  <health-effects>Flusilazole can cause testicular Leydig-cell tumours and bladder tumours in rats and hepatocellular tumours in mouse. An increased gestation length and increased placental weight have been found in the reproductive toxicity studies.</health-effects>
  <symptoms>Symptoms include weight loss, weakness, lethargy, alopecia and diarrhoea. At higher dose, prostration, salivation, laboured breathing, convulsions, and loss of righting reflex would be expected. Flusilazole can also cause mild erythema at the site of application.</symptoms>
  <treatment></treatment>
  <created-at type="dateTime">2013-04-25T07:56:51Z</created-at>
  <updated-at type="dateTime">2026-04-06T04:03:56Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia></wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id>C18733</kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id></chebi-id>
  <biocyc-id></biocyc-id>
  <ctd-id></ctd-id>
  <stitch-id></stitch-id>
  <drugbank-id></drugbank-id>
  <pdb-id></pdb-id>
  <actor-id></actor-id>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C[Si](CN1C=NC=N1)(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1</moldb-smiles>
  <moldb-formula>C16H15F2N3Si</moldb-formula>
  <moldb-inchi>InChI=1S/C16H15F2N3Si/c1-22(12-21-11-19-10-20-21,15-6-2-13(17)3-7-15)16-8-4-14(18)5-9-16/h2-11H,12H2,1H3</moldb-inchi>
  <moldb-inchikey>FQKUGOMFVDPBIZ-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">315.3927</moldb-average-mass>
  <moldb-mono-mass type="decimal">315.100330438</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp>3.7</logp>
  <hmdb-id>HMDB39815</hmdb-id>
  <chembl-id>CHEMBL1900522</chembl-id>
  <chemspider-id>66326</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM002811</chemdb-id>
  <dsstox-id>DTXSID3024235</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00098479</susdat-id>
  <iupac nil="true"/>
  <moldb-polar-surface-area>30.71</moldb-polar-surface-area>
  <moldb-refractivity>89.79</moldb-refractivity>
  <moldb-polarizability>29.397715658524767</moldb-polarizability>
  <moldb-rotatable-bond-count>4</moldb-rotatable-bond-count>
  <moldb-acceptor-count>2</moldb-acceptor-count>
  <moldb-donor-count>0</moldb-donor-count>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic>2.3191228608522807</moldb-pka-strongest-basic>
  <moldb-physiological-charge>0</moldb-physiological-charge>
  <moldb-number-of-rings>3</moldb-number-of-rings>
  <moldb-alogps-logp>3.55</moldb-alogps-logp>
  <moldb-alogps-logs>-4.86</moldb-alogps-logs>
  <moldb-alogps-solubility>4.33e-03 g/l</moldb-alogps-solubility>
</compound>
